Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer

To identify prostate cancer (PCa) patients with a high risk of recurrence is critical before delivering adjuvant treatment. We developed a classifier based on the Enzalutamide treatment resistance‐related genes to assist the currently available staging system in predicting the recurrence‐free surviv...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Chen, Jing, Meng, Jialin, Liu, Yi, Bian, Zichen, Niu, Qingsong, Chen, Junyi, Zhou, Jun, Zhang, Li, Zhang, Meng, Liang, Chaozhao
Format: Online Artikel Text
Sprache:English
Veröffentlicht: John Wiley and Sons Inc. 2022
Schlagworte:
Original Articles
Online Zugang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639034/
https://www.ncbi.nlm.nih.gov/pubmed/36168930
http://dx.doi.org/10.1111/jcmm.17554

Online

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639034/
https://www.ncbi.nlm.nih.gov/pubmed/36168930
http://dx.doi.org/10.1111/jcmm.17554

Ähnliche Einträge